Emerging technologies of polymeric nanoparticles in cancer drug delivery
暂无分享,去创建一个
[1] Samuel Zalipsky,et al. Chemistry of polyethylene glycol conjugates with biologically active molecules , 1995 .
[2] Rebecca Richards-Kortum,et al. Aptamer-Targeted Gold Nanoparticles As Molecular-Specific Contrast Agents for Reflectance Imaging , 2008, Bioconjugate chemistry.
[3] Francis C. Szoka,et al. pH-Sensitive Liposomes , 1994 .
[4] Weihong Tan,et al. Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. , 2003, Journal of the American Chemical Society.
[5] Sung Wan Kim,et al. Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.
[6] Weihong Tan,et al. Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers , 2008, ChemMedChem.
[7] Kazunori Kataoka,et al. Block copolymer micelles as long-circulating drug vehicles , 1995 .
[8] F. Szoka,et al. Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture , 1990, Pharmaceutical Research.
[9] K. Holli,et al. Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Robert Langer,et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.
[11] M. Dewhirst,et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. , 2000, Cancer research.
[12] Glen S. Kwon,et al. Methotrexate Esters of Poly(Ethylene Oxide)-Block-Poly(2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release , 2000, Pharmaceutical Research.
[13] Andrew D. Ellington,et al. Aptamer mediated siRNA delivery , 2006, Nucleic acids research.
[14] K. Kataoka,et al. Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[15] D. Tzemach,et al. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] K. Kono,et al. Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. , 2002, International journal of pharmaceutics.
[17] D Needham,et al. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. , 2000, Cancer research.
[18] E. Roux,et al. N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[19] R. Issels,et al. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. , 2007, Biochimica et biophysica acta.
[20] Atsushi Harada,et al. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. , 2003, Angewandte Chemie.
[21] K. Ozato,et al. Interactions of phospholipid vesicles with murine lymphocytes. I. Vesicle-cell adsorption and fusion as alternate pathways of uptake. , 1978, Membrane biochemistry.
[22] Lisa R. Hilliard,et al. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] Yingfu Li,et al. Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling. , 2004, Chemistry.
[24] M. Dewhirst,et al. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. , 2001, Cancer research.
[25] R. Finberg,et al. Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia , 1999 .
[26] H. Yoshioka. Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma. , 1991, Biomaterials.
[27] Yi-Yan Yang,et al. Synthesis and characterization of cationic micelles self-assembled from a biodegradable copolymer for gene delivery. , 2007, Biomacromolecules.
[28] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Dellian,et al. Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time , 2004, Clinical Cancer Research.
[30] M. Refojo,et al. Biodegradable microspheres for vitreoretinal drug delivery. , 2001, Advanced drug delivery reviews.
[31] G. Molineux. Pegylation: engineering improved pharmaceuticals for enhanced therapy. , 2002, Cancer treatment reviews.
[32] Kazunori Kataoka,et al. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. , 2005, Bioconjugate chemistry.
[33] Weihong Tan,et al. Development of Organic‐Dye‐Doped Silica Nanoparticles in a Reverse Microemulsion , 2004 .
[34] P. Cagnoni. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. , 2002, The Journal of antimicrobial chemotherapy.
[35] M. Dewhirst,et al. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. , 1996, International journal of radiation oncology, biology, physics.
[36] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[37] Wenjin Guo,et al. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[38] C. van Nostrum,et al. Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. , 2007, Biomaterials.
[39] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[40] Lasic Dd,et al. Sterically stabilized liposomes in cancer therapy and gene delivery. , 1999 .
[41] A. Hart,et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.
[42] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[43] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[44] A. Gabizon,et al. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[45] P. Low,et al. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[46] Marc Dellian,et al. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[47] Y. Oh,et al. pH‐sensitive, serum‐stable and long‐circulating liposomes as a new drug delivery system , 2002, The Journal of pharmacy and pharmacology.
[48] J. McNamara,et al. Cell-specific aptamers for targeted therapies. , 2009, Methods in molecular biology.
[49] Yen Wah Tong,et al. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. , 2009, Biomaterials.
[50] Teruo Okano,et al. Polymeric micelles as new drug carriers , 1996 .
[51] G. V. van Rhoon,et al. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[52] T. Park,et al. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[53] L. F. Fajardo,et al. Endothelial cells and hyperthermia. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[54] M. G. Rimoli,et al. Synthesis and characterisation of poly(D,L-lactic acid)-idoxuridine conjugate. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[55] G. Storm,et al. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[56] K. Jacobson,et al. Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. , 1973, Biochimica et biophysica acta.
[57] Teruo Okano,et al. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .
[58] M. Azori. Polymeric prodrugs. , 1987, Critical reviews in therapeutic drug carrier systems.
[59] D. Crommelin,et al. Controlled release of bioactive agents from lactide/glycolide polymers , 1990 .
[60] M. Sefton,et al. Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.
[61] K. Ulbrich,et al. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[62] Y Li,et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[63] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[64] M. Woodle,et al. Pharmacokinetics and anti‐tumor activity of vincristine encapsulated in sterically stabilized liposomes , 1995, International journal of cancer.
[65] D. Needham,et al. Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). , 1995, Biophysical journal.
[66] N. Nishiyama,et al. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. , 2007, Bioconjugate chemistry.
[67] Eunjung Kim,et al. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. , 2010, Biomaterials.
[68] G. Crile. Selective Destruction of Cancers After Exposure to Heat , 1962, Annals of surgery.
[69] Teruo Okano,et al. Physical Entrapment of Adriamycin in AB Block Copolymer Micelles , 1995, Pharmaceutical Research.
[70] M. Alonso,et al. Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration , 1998, Pharmaceutical Research.
[71] A. Gabizon. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.
[72] Y. Ohya,et al. Biodegradable polymeric materials , 2008 .
[73] V. Zurawski,et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. , 1992, Cancer research.
[74] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[75] P. Volberding,et al. Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.
[76] D. Lasič. Novel applications of liposomes. , 1998, Trends in biotechnology.
[77] J. Sturtevant,et al. Investigation of phase transitions of lipids and lipid mixtures by high sensitivity differential scanning calorimetry ( lipid bilayers / membranes / phase diagrams / transition heat capacity curves ) , 2022 .
[78] T. Okano,et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.
[79] Kazunori Kataoka,et al. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. , 2005, Molecular bioSystems.
[80] John Samuel,et al. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.
[81] P. Low,et al. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. , 1999, Journal of drug targeting.
[82] T. Okano,et al. Biodistribution of Micelle-Forming Polymer–Drug Conjugates , 1993, Pharmaceutical Research.
[83] P. Low,et al. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors , 2002, Cancer Immunology, Immunotherapy.
[84] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[85] F. Szoka,et al. Surface aggregation and membrane penetration by peptides: relation to pore formation and fusion. , 1999, Molecular membrane biology.
[86] S. Zorzet,et al. Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates. , 2003, Farmaco.
[87] Dayan Ad. Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl). , 1996 .
[88] J. Blay,et al. Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: A phase III randomised pros , 2007 .
[89] C. van Nostrum,et al. Physicochemical characterization of degradable thermosensitive polymeric micelles. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[90] C. McArdle,et al. Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. , 1986, British Journal of Cancer.
[91] T. Okano,et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. , 1990, Cancer research.
[92] Ioanis Katakis,et al. Aptamers: molecular tools for analytical applications , 2008, Analytical and bioanalytical chemistry.
[93] Robert Langer,et al. Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. , 2005, Analytical chemistry.
[94] Yong Wang,et al. Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras , 2006, Nature Biotechnology.
[95] Joshua E. Smith,et al. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. , 2007, Analytical chemistry.
[96] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[97] James L Mulshine,et al. Lung cancer screening. , 2005, The oncologist.
[98] R. Finberg,et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1999, The New England journal of medicine.
[99] Wim E Hennink,et al. Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): a new class of biodegradable polymers with tuneable thermosensitivity. , 2004, Biomacromolecules.
[100] Kyung-Dall Lee,et al. Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin* , 2003, Journal of Biological Chemistry.
[101] J. Blay,et al. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. , 2001, European journal of cancer.
[102] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[103] Werner Tjarks,et al. A novel pH-sensitive liposome formulation containing oleyl alcohol. , 2002, Biochimica et biophysica acta.
[104] Xiabin Jing,et al. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate. , 2005, Biomaterials.
[105] Sérgio Simões,et al. On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.
[106] H. Kawaide,et al. Antisense and chemical suppression of the nonmevalonate pathway affects ent-kaurene biosynthesis in Arabidopsis , 2002, Planta.
[107] T. Park,et al. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[108] P. Low,et al. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[109] A. Eggermont,et al. Pegylated liposomal tumor necrosis factor‐α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil®) in soft tissue sarcoma‐bearing rats , 2002, International journal of cancer.
[110] T. Ishida,et al. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. , 2001, Biochimica et biophysica acta.
[111] W. Jiskoot,et al. Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins* , 2002, The Journal of Biological Chemistry.
[112] Tae Gwan Park,et al. Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[113] J M Sturtevant,et al. Investigation of phase transitions of lipids and lipid mixtures by sensitivity differential scanning calorimetry. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[114] Weihong Tan,et al. DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells , 2009, Proceedings of the National Academy of Sciences.
[115] M. N. Jones,et al. Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. , 2000, Biochimica et biophysica acta.
[116] Ivan Spasojevic,et al. Phase I Trial of Doxorubicin-Containing Low Temperature Sensitive Liposomes in Spontaneous Canine Tumors , 2006, Clinical Cancer Research.
[117] Wim E. Hennink,et al. Thermoresponsive Polymeric Micelles with Controlled Instability Based on Hydrolytically Sensitive N-Isopropylacrylamide Copolymers , 2001 .
[118] C. Walsh. Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.
[119] R Blumenthal,et al. Design of liposomes for enhanced local release of drugs by hyperthermia. , 1978, Science.
[120] M. Woodle,et al. Sterically stabilized liposome therapeutics , 1995 .
[121] R. Nicholson,et al. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. , 2005, Endocrine-related cancer.
[122] T. Tsong. Kinetics of the crystalline-liquid crystalline phase transition of dimyristoyl L-alpha-lecithin bilayers. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[123] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[124] Gabriele Bergers,et al. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. , 2000, The Journal of clinical investigation.
[125] T. Park,et al. Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release , 1999, Pharmaceutical Research.
[126] Omid C Farokhzad,et al. Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates , 2007, ChemMedChem.
[127] T. Allen. Liposomal drug formulations. Rationale for development and what we can expect for the future. , 1998, Drugs.
[128] Chih-Ching Huang,et al. Aptamer-functionalized gold nanoparticles for turn-on light switch detection of platelet-derived growth factor. , 2007, Analytical chemistry.
[129] G. F. Joyce,et al. Amplification, mutation and selection of catalytic RNA. , 1989, Gene.
[130] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[131] C. van Nostrum,et al. Novel fast degradable thermosensitive polymeric micelles based on PEG-block-poly(N-(2-hydroxyethyl)methacrylamide-oligolactates). , 2005, Biomacromolecules.
[132] M. Dewhirst,et al. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. , 2000, Cancer research.
[133] M. Mascini,et al. Aptamer-based biosensors for the detection of HIV-1 Tat protein. , 2005, Bioelectrochemistry.
[134] T. Park,et al. Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[135] Yokoyama Masayuki,et al. Block copolymer micelles as vehicles for drug delivery , 1993 .
[136] Weihong Tan,et al. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. , 2006, Analytical chemistry.
[137] Teruo Okano,et al. Block copolymer micelles for drug delivery: Loading and release of doxorubicin , 1997 .
[138] Wim E Hennink,et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[139] P. Working,et al. Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl). , 1996, Human & experimental toxicology.
[140] S. Takahashi,et al. Interaction of fusogenic synthetic peptide with phospholipid bilayers: orientation of the peptide alpha-helix and binding isotherm. , 1996, Biochemistry.